These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29124816)

  • 1. The Cannabis Abuse Screening Test and the DSM-5 in the general population: Optimal thresholds and underlying common structure using multiple factor analysis.
    Legleye S
    Int J Methods Psychiatr Res; 2018 Jun; 27(2):e1597. PubMed ID: 29124816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of the Cannabis Abuse Screening Test (CAST) in the general population.
    Legleye S; Guignard R; Richard JB; Ludwig K; Pabst A; Beck F
    Int J Methods Psychiatr Res; 2015 Jun; 24(2):170-83. PubMed ID: 26077195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A validation of the Cannabis Abuse Screening Test (CAST) using a latent class analysis of the DSM-IV among adolescents.
    Legleye S; Piontek D; Kraus L; Morand E; Falissard B
    Int J Methods Psychiatr Res; 2013 Mar; 22(1):16-26. PubMed ID: 23519957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of the CAST and SDS scales in young adult cannabis users.
    Cuenca-Royo AM; Sánchez-Niubó A; Forero CG; Torrens M; Suelves JM; Domingo-Salvany A
    Addict Behav; 2012 Jun; 37(6):709-15. PubMed ID: 22386300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal scaling of the CAST and of SDS Scale in a national sample of adolescents.
    Bastiani L; Siciliano V; Curzio O; Luppi C; Gori M; Grassi M; Molinaro S
    Addict Behav; 2013 Apr; 38(4):2060-7. PubMed ID: 23396173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents.
    Legleye S; Piontek D; Kraus L
    Drug Alcohol Depend; 2011 Jan; 113(2-3):229-35. PubMed ID: 20869178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Cannabis Abuse Screening Test in a sample of cannabis inpatients.
    Legleye S; Kraus L; Piontek D; Phan O; Jouanne C
    Eur Addict Res; 2012; 18(4):193-200. PubMed ID: 22472963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age Invariance of the Cannabis Abuse Screening Test in a Probabilistic Sample of Cannabis Users.
    Legleye S; Rouquette A
    Eur Addict Res; 2018; 24(1):37-42. PubMed ID: 29495016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric properties of the Spanish version of the Cannabis Use Problems Identification Test among Chilean university students: A validation study.
    Cantillano V; Del Villar P; Contreras L; Martínez D; Zuzulich MS; Ramírez C; Pons C; Bashford J
    Drug Alcohol Depend; 2017 Jan; 170():32-36. PubMed ID: 27866060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the Cannabis Abuse Screening Test in Hungarian samples of adolescents and young adults.
    Gyepesi A; Urbán R; Farkas J; Kraus L; Piontek D; Paksi B; Horváth G; Magi A; Eisinger A; Pilling J; Kökönyei G; Kun B; Demetrovics Z
    Eur Addict Res; 2014; 20(3):119-28. PubMed ID: 24217457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of cannabis-related problems among youth: the CPQ-A-S and CAST questionnaires.
    Fernandez-Artamendi S; Fernández-Hermida JR; Muñiz-Fernández J; Secades-Villa R; García-Fernández G
    Subst Abuse Treat Prev Policy; 2012 Apr; 7():13. PubMed ID: 22471908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DSM Guided Cannabis Screen (DSM-G-CS): description, reliability, factor structure and empirical scoring with a clinical sample.
    Alexander D; Leung P
    Addict Behav; 2011 Nov; 36(11):1095-100. PubMed ID: 21741769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis dimensionality: dependence, abuse and consumption.
    Beseler CL; Hasin DS
    Addict Behav; 2010 Nov; 35(11):961-9. PubMed ID: 20598807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of cannabis dependence in the community.
    Teesson M; Lynskey M; Manor B; Baillie A
    Drug Alcohol Depend; 2002 Dec; 68(3):255-62. PubMed ID: 12393220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use.
    El Malki H; Moutawakkil SG; El-Ammari A; Ragala MEA; El Hilaly J; El Gnaoui S; El Houari F; El Rhazi K; Zarrouq B
    Addict Sci Clin Pract; 2024 Apr; 19(1):24. PubMed ID: 38570799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cannabis Use Problems Identification Test (CUPIT): development, reliability, concurrent and predictive validity among adolescents and adults.
    Bashford J; Flett R; Copeland J
    Addiction; 2010 Apr; 105(4):615-25. PubMed ID: 20403014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening tools for cannabis use disorders and their adaptation to DSM-5: A literature review].
    Artigaud L; Fener C; Bisch M; Schwan R; Schwitzer T; De Ternay J; Adamson SJ; Rolland B; Laprévote V
    Encephale; 2020 Oct; 46(5):382-389. PubMed ID: 32475691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the structure of the CAST (Cannabis Abuse Screening Test) in 13 European countries using multigroup analyses.
    Legleye S; Eslami A; Bougeard S
    Int J Methods Psychiatr Res; 2017 Mar; 26(1):. PubMed ID: 27981662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the proposed DSM-5 cannabis use disorder criteria using Australian national survey data.
    Mewton L; Slade T; Teesson M
    J Stud Alcohol Drugs; 2013 Jul; 74(4):614-21. PubMed ID: 23739026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cannabis Abuse Screening Test (CAST) revisited: examining measurement invariance by age.
    Sznitman SR
    Int J Methods Psychiatr Res; 2017 Dec; 26(4):. PubMed ID: 27723274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.